Serina Therapeutics, Inc. (SER)
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Serina Therapeutics, Inc.
NYSE:SERHealthcare · Biotechnology
-6.25%$1.65
AH Close$1.65+0.00%vs close
AH Close$1.65+0.00%vs close
Mkt Cap$41.91M
Float4.47M
O/S25.4M
Inst Own5.5%
SI1.3%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$19.18M
Total Assets$6.95M
Free Cash Flow-$17.95M
Debt & Equity
Debt 4%
Preferred 97%
Total Debt$196K
Total Equity-$37K
Preferred Stock$4.94M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in SER's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$6.95M
Liabilities$6.99M
Accounts Receivable$0
Accounts Payable$1.93M
Inventory$0
PP&E (Net)$842K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Revenue | $0 | $56K | $3.15M | $500K | $3.46M | $54K | $1.73M | $1.4M | $1.4M | $1.67M |
| YoY Growth | - | -98.2% | 530.6% | -85.6% | 6316.2% | -96.9% | 23.8% | -0.6% | -15.7% | - |
| Cost of Revenue | $0 | $194K | $90K | $0 | $3.8M | $1.28M | $999K | $841K | $685K | $911K |
| Gross Profit | $0 | -$138K | $3.06M | $500K | -$334K | -$1.23M | $730K | $555K | $719K | $755K |
| Gross Margin | - | -246.4% | 97.1% | 100.0% | -9.6% | -2272.2% | 42.2% | 39.8% | 51.2% | 45.3% |
| Research and Development | $13.15M | $7.48M | $2.39M | $1.57M | $3.8M | $3.58M | $5.35M | $5.35M | $5.27M | $7.87M |
| Selling, General, and Administrative | $11M | $9.43M | $3.89M | $1.29M | $1.3M | $5.6M | $7.94M | $5.65M | $3.87M | $5.62M |
| Other | -$130K | $0 | -$90K | -$92K | -$3.8M | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $24.02M | $16.91M | $6.19M | $2.77M | $1.3M | $9.18M | $13.29M | $11M | $9.14M | $13.49M |
| Operating Income (EBIT) | -$24.02M | -$17.05M | -$3.13M | -$2.27M | -$1.63M | -$10.41M | -$12.56M | -$10.45M | -$8.42M | -$12.74M |
| Operating Margin | - | -30442.9% | -99.2% | -454.1% | -47.1% | -19272.2% | -726.8% | -748.2% | -599.5% | -764.6% |
| Interest Expense | $213K | $526K | $558K | $16K | $3K | $404K | $0 | $0 | $12K | $25K |
| Interest Income | $0 | $0 | $0 | $2K | $11K | $0 | $29K | $116K | $0 | $0 |
| Other Income (Expense) | $4.83M | $5.84M | $8.4M | -$412K | $367K | $8K | $323K | $2.71M | $1.78M | -$4.62M |
| Income Before Tax (EBT) | -$19.2M | -$11.21M | $5.27M | -$2.68M | -$1.26M | -$10.4M | -$12.24M | -$7.73M | -$6.64M | -$17.36M |
| Income Tax Expense | $18K | $0 | $0 | $0 | $0 | $0 | $148K | $0 | $0 | $0 |
| Net Income | -$19.18M | -$11.14M | $5.27M | -$2.68M | -$1.26M | -$10.87M | -$12.15M | -$7.5M | -$6.58M | -$15.49M |
| Net Income Margin | - | -19894.6% | 167.1% | -536.4% | -36.5% | -20120.4% | -703.4% | -537.4% | -468.7% | -929.9% |
| Supplementary Data | ||||||||||
| EPS | -1.91 | -1.51 | 0.63 | -2.49 | -0.59 | -10.14 | -11.47 | -7.56 | -6.46 | -15.21 |
| Diluted EPS | -1.91 | -1.51 | 0.63 | -2.49 | -0.59 | -10.14 | -11.47 | -7.56 | -6.46 | -15.21 |
| Weighted Average OS | 10.19M | 7.36M | 8.41M | 1.08M | 1.08M | 1.07M | 1.06M | 992,721 | 1.02M | 1.02M |
| EBITDA | -$18.91M | -$10.49M | $5.92M | -$2.6M | -$1.23M | -$8.74M | -$11.29M | -$7.2M | -$7.74M | -$11.89M |
| EBITDA Margin | - | -18726.8% | 187.7% | -521.0% | -35.4% | -16185.2% | -653.1% | -515.5% | -550.9% | -713.9% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash and Cash Equivalents | $3.06M | $3.67M | $7.62M | $645K | $584K | $527K | $2.35M | $6.71M | $7.38M | $259K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $3.06M | $3.67M | $7.62M | $645K | $584K | $527K | $2.35M | $6.71M | $7.38M | $259K |
| Accounts Receivable | $0 | $0 | $0 | $4K | $25K | $326K | $363K | $131K | $107K | $308K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $3.02M | $77K | $0 | $1.8M | $1.63M | $1.43M | $1.34M | $1.01M | $111K | $121K |
| Total Current Assets | $6.08M | $5.68M | $7.62M | $2.45M | $2.23M | $2.28M | $4.05M | $7.85M | $7.59M | $688K |
| Long-Term Assets | ||||||||||
| Property, Plant & Equipment Net | $842K | $1.05M | $1.35M | $0 | $0 | $0 | $1.13M | $90K | $129K | $195K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $738K | $0 | $1.59M | $2.15M | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $50K | $50K | $50K | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $29K | $0 | $0 | $0 | $870K | $0 | $111K | $2.73M | $1.91M | $2.34M |
| Total Long-Term Assets | $871K | $1.05M | $1.35M | $788K | $920K | $1.64M | $3.39M | $2.82M | $2.04M | $2.54M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $6.95M | $6.72M | $8.97M | $3.24M | $3.15M | $3.92M | $7.44M | $10.67M | $9.63M | $3.22M |
| Liabilities | ||||||||||
| Current Liabilities | ||||||||||
| Accounts Payable | $1.93M | $744K | $580K | $568K | $193K | $761K | $420K | $150K | $75K | $261K |
| Short-Term Debt | $0 | $0 | $0 | $7.65M | $7.14M | $2.4M | $428K | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $275K | $283K | $317K | $180K | $264K |
| Other Current Liabilities | $1.63M | $1.06M | $250K | $1.67M | $1.63M | $1.93M | $2.17M | $1.97M | $1.06M | $25.07M |
| Total Current Liabilities | $3.56M | $2.37M | $1.41M | $10.08M | $8.97M | $5.36M | $3.3M | $2.44M | $1.31M | $25.6M |
| Long-Term Liabilities | ||||||||||
| Long-Term Debt | $196K | $0 | $2.98M | $10.48M | $6.06M | $3.9M | $1.53M | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $64K | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $3.23M | $3.58M | $36.4M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $3.42M | $3.85M | $39.85M | $10.48M | $6.06M | $3.96M | $1.53M | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $6.99M | $6.22M | $41.26M | $20.56M | $15.03M | $9.32M | $4.83M | $2.44M | $1.31M | $25.6M |
| Stockholders' Equity | ||||||||||
| Preferred Stock | $4.94M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $1K | $1K | $0 | $4K | $4K | $4K | $4K | $4K | $3K | $3K |
| Retained Earnings | -$63.5M | -$44.32M | -$33.18M | -$116.21M | -$105.75M | -$97.07M | -$86.21M | -$74.05M | -$66.55M | -$59.97M |
| Comprehensive Income & Other | -$14K | $0 | $0 | $0 | $0 | $143K | $69K | -$2K | $68K | $58K |
| Other Stockholders' Equity | $63.46M | $44.96M | $883K | $98.99M | $93.91M | $91.95M | $88.42M | $81.5M | $73.83M | $36.55M |
| Total Equity | -$37K | $641K | -$32.29M | -$17.21M | -$11.83M | -$5.12M | $2.22M | $7.45M | $7.28M | -$23.42M |
| Minority Interest | $0 | -$133K | $0 | -$103K | -$43K | -$280K | $399K | $784K | $1.04M | $1.04M |
| Total Liabilities and Equity | $6.95M | $6.86M | $8.97M | $3.34M | $3.2M | $4.21M | $7.04M | $9.89M | $8.59M | $2.18M |
| Supplementary Data | ||||||||||
| Total Debt | $196K | $268K | $3.44M | $18.12M | $13.2M | $6.3M | $1.96M | $0 | $0 | $0 |
| Net Debt | -$2.86M | -$3.4M | -$4.17M | $17.48M | $12.62M | $5.77M | -$396K | -$6.71M | -$7.38M | -$259K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Operating Activities | ||||||||||
| Net Income | -$19.44M | -$11.21M | $5.27M | -$2.68M | -$1.26M | -$10.39M | -$12.15M | -$7.5M | -$6.58M | -$15.49M |
| Depreciation & Amortization | $73K | $194K | $90K | $61K | $33K | $1.25M | $951K | $535K | $682K | $845K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $3.79M | $2.6M | $25K | $7K | $83K | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||||||
| Accounts Receivable | $0 | $65K | $0 | $1K | $1.27M | -$30K | -$232K | -$24K | $322K | -$57K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $1.2M | -$1.66M | $393K | -$2K | -$367K | $382K | $169K | $648K | $267K | $1.24M |
| Other Working Capital | $273K | -$1.72M | -$312K | -$11K | -$1.66M | -$612K | -$347K | -$413K | $187K | $124K |
| Total Working Capital Change | $1.47M | -$3.32M | $81K | -$12K | -$755K | -$260K | -$410K | $211K | $776K | $1.31M |
| Other Non-Cash Items | -$3.85M | -$5.4M | -$7.94M | $550K | -$348K | $1.58M | $1.45M | -$1.24M | -$1.16M | $4.91M |
| Net Cash from Operating | -$17.95M | -$17.14M | -$2.48M | -$2.08M | -$2.25M | -$7.82M | -$10.16M | -$8M | -$6.29M | -$8.43M |
| Investing Activities | ||||||||||
| Capital Expenditures | -$59K | -$22K | -$504K | -$10K | -$108K | -$20K | -$641K | -$1.89M | -$1K | -$23K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $991K | $932K | $0 | $354K | $3.21M | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | -$74K | $5K | $6K | -$5K |
| Net Cash from Investing | -$59K | -$22K | -$504K | $981K | $823K | -$20K | -$361K | $1.33M | $5K | -$28K |
| Financing Activities | ||||||||||
| Debt Repaid | -$4.91M | -$2.88M | -$10.05M | -$1.31M | $13K | -$5.53M | -$1.76M | - | - | - |
| Common Stock Issuance | $12.5M | $5M | $15K | $4K | $0 | $0 | $4.5M | $6M | $11.97M | $2.45M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $5.34M | $0 | $0 | $1M | $0 | $0 | $0 | $1.3M | $4.81M |
| Net Cash from Financing | $17.41M | $13.21M | $10.07M | $1.31M | $1.08M | $5.96M | $6.26M | $6M | $13.28M | $7.25M |
| Forex Effect | -$14K | $0 | $0 | $0 | $0 | $51K | -$99K | $0 | $121K | $0 |
| Net Change in Cash | -$616K | -$3.95M | $7.09M | $217K | -$350K | -$1.82M | -$4.36M | -$668K | $7.12M | -$1.2M |
| Supplementary Data | ||||||||||
| Operating Cash Flow | -$17.95M | -$17.14M | -$2.48M | -$2.08M | -$2.25M | -$7.82M | -$10.16M | -$8M | -$6.29M | -$8.43M |
| Capital Expenditure | -$59K | -$22K | -$504K | -$10K | -$108K | -$20K | -$641K | -$1.89M | -$1K | -$23K |
| Free Cash Flow | -$17.95M | -$17.16M | -$2.98M | -$2.09M | -$2.36M | -$7.84M | -$10.8M | -$9.89M | -$6.29M | -$8.45M |
| Cash at Beginning | $3.67M | $7.62M | $532K | $315K | $665K | $2.35M | $6.71M | $7.38M | $259K | $1.46M |
| Cash at End | $3.06M | $3.67M | $7.62M | $532K | $315K | $527K | $2.35M | $6.71M | $7.38M | $259K |